Prognos
Improving Health by Predicting Disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€85—127m (Dealroom.co estimates May 2023.)
New York City New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $750k | Convertible | |
$7.0m | Series A | ||
$15.0m | Series B | ||
$20.5m | Series C | ||
* | $23.3m | Late VC | |
Total Funding | €60.5m |
Related Content
Recent News about Prognos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Prognos
EditACQUISITION by Prognos Sep 2013
ACQUISITION by Prognos Mar 2012